Aurobindo Pharma Ltd. (AUROPHARMA)
NSE
Closed
Sep 9, 2026
Day's Range
1,672.0052 wk Range
1,036.00Overview - AUROPHARMA - Aurobindo Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
925.74B
P/E (Trailing)
‪25.97‬
P/E (Forward)
‪17.74‬
PEG Ratio
‪1.75‬
Price / Sales (TTM)
‪2.71‬
Price / Book
‪2.52‬
EV / EBITDA
‪13.18‬
Profitability
Gross Margin
‪60.16%‬
Profit Margin
‪10.62%‬
Operating Margin
‪15.23%‬
Return on Assets
‪5.99%‬
Return on Equity
‪9.25%‬
Ownership
Shares Outstanding
575.37M
Float
276.08M
Held by Insiders
‪54.78%‬
Held by Institutions
‪30.57%‬
Price stats
Beta
‪0.02‬
50-Day Avg
‪1,596.26‬
200-Day Avg
‪1,374.72‬
Dividends
Payout Ratio
‪6.25%‬
Frequency
Semi-Annual
Analyst Consensus
27 analysts
Average price target
‪₹ 1,678.32‬Market Cap - AUROPHARMA - Aurobindo Pharma Ltd.
Peers - AUROPHARMA - Aurobindo Pharma Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
- AUROPHARMANSEAurobindo Pharma Ltd.951.15BMarket Cap+37.08%52-week change25.98P/E (Trailing)‪10.62%‬Profit Margin
- DIVISLABNSEDivi's Laboratories Ltd.2.45TMarket Cap+34.05%52-week change95.31P/E (Trailing)‪26.04%‬Profit Margin
- CIPLANSECipla Ltd.1.14TMarket Cap-11.50%52-week change34.09P/E (Trailing)‪12.00%‬Profit Margin
- LAURUSLABSNSELaurus Labs Ltd.1.04TMarket Cap+55.80%52-week change95.68P/E (Trailing)‪15.04%‬Profit Margin
- LUPINNSELupin Ltd.992.95BMarket Cap+12.96%52-week change18.10P/E (Trailing)‪18.45%‬Profit Margin
- DRREDDYNSEDr. Reddy's Laboratories Ltd.981.26BMarket Cap-8.65%52-week change29.70P/E (Trailing)‪9.99%‬Profit Margin
- MANKINDNSEMankind Pharma Ltd.953.72BMarket Cap-15.82%52-week change46.78P/E (Trailing)‪13.85%‬Profit Margin
Profile Summary - AUROPHARMA - Aurobindo Pharma Ltd.
About
Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in the manufacturing and marketing of a broad range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The primary function of Aurobindo Pharma is to supply affordable healthcare products and solutions across a variety of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
